Login / Signup
Cytomegalovirus Reactivation During Elotuzumab Therapy in Patients with Multiple Myeloma.
Taku Kikuchi
Nobuhiro Tsukada
Kodai Kunisada
Moe Nomura-Yogo
Yuki Oda
Kota Sato
Tomomi Takei
Mizuki Ogura
Yu Abe
Kenshi Suzuki
Tadao Ishida
Published in:
Acta haematologica (2024)
Although the patient population was heterogeneous, CMVRA cannot be underestimated during elotuzumab therapy, and evaluation of CMVRA, especially in symptomatic cases, is clinically important.
Keyphrases
</>
multiple myeloma
mesenchymal stem cells
cell therapy
smoking cessation